BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Biologics Market Size to Exceed USD 1,144.20 Billion by 2034 Amid Rising Demand for Monoclonal Antibodies, Vaccines, and Personalized Therapies

  October 14, 2025

   · 

  1 min read
• 

  Manufacturing

  Violations at Novo’s Indiana Plant ‘Unacceptable,’ FDA Says

  Slapped with the most severe post-inspection classification, the state of Novo Nordisk’s Indiana manufacturing site could pose a problem for clients, including Regeneron and Scholar Rock.

  October 14, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Alzheimer’s disease

  Roche, Lilly Win First FDA Nod for Alzheimer’s Blood Test for Primary Care Use

  Elecsys’ approval could help boost the uptake of currently approved Alzheimer’s disease therapies, including Biogen’s Eisai-partnered Leqembi, with CEO Chris Viehbacher recently noting that such biomarker-based tests could “remove some of the bottlenecks” in uptake.

  October 14, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Series B

  Kailera Banks Massive $600M Raise for Phase III Obesity Study

  Kailera’s lead asset, KAI-9531, elicited an average weight loss of more than 17% in a Phase III study in China. The biotech expects to launch a global late-stage program for the drug this year.

  October 14, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Earnings

  No Trump Drug Pricing Plan for J&J—Yet

  Reporting third quarter earnings on Tuesday, Johnson & Johnson CEO Joaquin Duato said the healthcare giant has not yet secured a drug pricing deal with the White House, but discussions are ongoing.

  October 14, 2025

   · 

  3 min read

   · 

  Annalee Armstrong
• Press Releases

  Sharp Therapeutics Arranges Non-Brokered Private Placement

  October 14, 2025

   · 

  1 min read
• Press Releases

  Nona Biosciences Appoints Dr. Di Hong as Chief Executive Officer to Drive Technology Innovation and Strategic Growth

  October 14, 2025

   · 

  4 min read
• Press Releases

  Astellas to Present First Real-World VEOZAH™ (fezolinetant) Data at 2025 Annual Meeting of The Menopause Society

  October 14, 2025

   · 

  8 min read
• Press Releases

  Orum Therapeutics Appoints Dr. Dorin Toader as Head of Platform Technology to Advance Orum’s Degrader–Antibody Conjugate Payload Platforms and Expand TPD²® Therapeutic Applications

  October 14, 2025

   · 

  4 min read